share_log

騰盛博藥-B:(1)建議採納經審核合併財務報表;(2)建議重選退任董事;(3)建議續聘核數師;(4)建議發行及購回股份之一般授權;及(5)股東週年大會通告

BRII-B: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; AND (5) NOTICE OF ANNUAL GENERAL MEETING

May 19, 2022 19:36
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more